IP Library Granted Patent US 9,604,948
Granted Patent B2
US 9,604,948 · App. 14/796,703 · Granted Mar 28, 2017

Process for preparing substituted 5-fluoro-1H-pyrazolopyridines

Inventors: Peter Fey (Wuppertal, DE); Alfons Grunenberg (Wuppertal, DE); Donald Bierer (Haan, DE)
Assignee: ADVERIO PHARMA GMBH
C07D295/104C07C303/28C07C309/04C07C317/04C07D265/30C07D295/067C07D471/04C07B2200/13
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,604,948
App. No.
14/796,703
Granted
Mar 28, 2017
Kind
B2
Abstract

The present application relates to a novel and efficient process for preparing novel substituted 5-fluoro-1H-pyrazolopyridines of the formula (VI) which are suitable as an intermediate for production of medicaments and for production of medicaments for treatment and/or prophylaxis of cardiovascular disorders. More particularly, the 5-fluoro-1H-pyrazolopyridines of the formula (VI) are suitable for preparation of the compound of the formula (I) which serves for production of medicaments, for production of medicaments for treatment and/or prophylaxis of cardiovascular disorders.

Claims (10)

1. A compound of formula (I) in crystalline form of polymorph I

wherein the x-ray diffractogram of the compound exhibits peak maxima of the 2 theta angle at 5.9, 6.9, 22.7.

2. The compound of claim 1 , wherein the x-ray diffractogram of the compound exhibits peak maxima of the 2 theta angle at 5.9, 6.9, 16.2, 16.5, 24.1, 22.7, 24.7.

3. The compound of claim 1 , wherein the IR spectrum of the compound exhibits band maxima at 1707, 1633, 1475 cm −1 .

4. The compound of claim 3 , wherein the IR spectrum of the compound exhibits band maxima at 1707, 1633, 1566, 1475, 1255, 1223 cm −1 .

5. A process for preparing the compound of claim 1 , comprising:

stirring a solution of compounds of formula (I), wherein the compounds of formula (I) are present in one or more polymorphs or as a solvate in an inert solvent, at a temperature of 20° C.-120° C., and isolating the compound of formula (I) in the form of crystalline polymorph I from the solution.

6. A solid pharmaceutical composition comprising a compound of claim 1 and no greater proportion of any other form of the compound of the formula (I).

7. A solid pharmaceutical composition comprising a compound of claim 1 in more than 90 percent by weight based on the total amount any other form of the compound of the formula (I) present.

8. A method for treatment of cardiovascular disorders by administering an effective amount of the compound of claim 1 to a patient in need thereof.

Assignments (7)
CHANGE OF PATENTEE ADDRESS Recorded Feb 8, 2021
From: ADVERIO PHARMA GMBH
To: ADVERIO PHARMA GMBH
Reel/Frame 056907/0570 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 5, 2018
From: BAYER PHARMA AKTIENGESELLSCHAFT
To: BAYER INTELLECTUAL PROPERTY GMBH
Reel/Frame 046790/0583 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 5, 2018
From: BAYER INTELLECTUAL PROPERTY GMBH
To: ADVERIO PHARMA GMBH
Reel/Frame 046790/0738 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNOR'S NAME PREVIOUSLY RECORDED AT REEL: 046254 FRAME: 0619. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Jul 6, 2018
From: FEY, PETER; GRUNENBERG, ALFONS; BIERER, DONALD
To: BAYER PHARMA AKTIENGESELLSCHAFT
Reel/Frame 046493/0254 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 2, 2018
From: FEY, PETE; GRUNENBERG, ALFONS; BIERER, DONALD
To: BAYER PHARMA AKTIENGESELLSCHAFT
Reel/Frame 046254/0619 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 17, 2016
From: BAYER INTELLECTUAL PROPERTY GMBH
To: ADVERIO PHARMA GMBH
Reel/Frame 038614/0772 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 29, 2016
From: FEY, PETER; GRUNENBERG, ALFONS; BIERER, DONALD
To: BAYER INTELLECTUAL PROPERTY GMBH
Reel/Frame 038583/0553 →
Priority Claims (2)
EP 11190789 · Nov 25, 2011 · regional
EP 11192301 · Dec 7, 2011 · regional
Continuity (3)
Division 14320875 · Jul 1, 2014
Division 13684670 · Nov 26, 2012
Related Publication 20160009671A1 · Jan 14, 2016